See more : Dohwa Engineering Co., Ltd. (002150.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Cyclopharm Limited (CYC.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cyclopharm Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- Velan Inc. (VLNSF) Income Statement Analysis – Financial Results
- Matrimony.com Limited (MATRIMONY.NS) Income Statement Analysis – Financial Results
- Society Pass Incorporated (SOPA) Income Statement Analysis – Financial Results
- TG Venture Acquisition Corp. (TGVCU) Income Statement Analysis – Financial Results
- Toyo Suisan Kaisha, Ltd. (2875.T) Income Statement Analysis – Financial Results
Cyclopharm Limited (CYC.AX)
About Cyclopharm Limited
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes third party products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.14M | 23.22M | 17.70M | 14.68M | 14.08M | 13.40M | 13.19M | 14.39M | 12.58M | 12.05M | 11.88M | 10.74M | 10.31M | 9.46M | 13.11M | 10.89M | 11.13M |
| Cost of Revenue | 22.64M | 17.28M | 14.50M | 12.60M | 9.21M | 7.76M | 6.84M | 7.24M | 6.12M | 3.43M | 3.51M | 3.35M | 3.13M | 2.31M | 2.55M | 2.53M | 3.12M |
| Gross Profit | 4.50M | 5.94M | 3.20M | 2.08M | 4.87M | 5.64M | 6.35M | 7.15M | 6.46M | 8.62M | 8.37M | 7.40M | 7.19M | 7.16M | 10.57M | 8.36M | 8.01M |
| Gross Profit Ratio | 16.57% | 25.58% | 18.09% | 14.17% | 34.56% | 42.11% | 48.17% | 49.68% | 51.35% | 71.55% | 70.47% | 68.83% | 69.68% | 75.60% | 80.58% | 76.75% | 71.95% |
| Research & Development | 3.69M | 3.44M | 1.66M | 3.54M | 4.19M | 3.22M | 2.87M | 1.16M | 726.99K | 14.23K | 37.51K | 22.74K | 0.00 | 16.85K | 39.73K | 35.99K | 28.76K |
| General & Administrative | 14.00M | 10.96M | 10.79M | 9.47M | 6.38M | 5.57M | 5.38M | 5.10M | 3.99M | 4.27M | 4.78M | 4.44M | 3.45M | 4.08M | 4.83M | 5.11M | 5.38M |
| Selling & Marketing | 2.05M | 2.92M | 1.02M | 845.72K | 644.62K | 755.49K | 801.89K | 750.37K | 791.79K | 777.40K | 938.17K | 930.88K | 584.05K | 581.31K | 655.85K | 652.23K | 660.04K |
| SG&A | 16.05M | 9.78M | 7.98M | 6.62M | 6.56M | 4.96M | 4.83M | 3.97M | 3.16M | 5.05M | 5.72M | 5.37M | 4.04M | 4.66M | 5.49M | 5.76M | 6.04M |
| Other Expenses | 0.00 | 1.76M | 2.69M | 2.85M | 4.09M | 2.49M | 2.37M | -17.55K | 1.97M | 2.41M | 141.01K | -203.36K | -207.10K | 1.23M | 482.44K | 49.38K | 101.41K |
| Operating Expenses | 13.38M | 13.22M | 9.64M | 10.16M | 10.76M | 8.18M | 7.70M | 5.12M | 3.88M | 7.54M | 8.93M | 7.84M | 7.46M | 5.91M | 7.65M | 6.26M | 6.49M |
| Cost & Expenses | 36.02M | 30.50M | 24.14M | 22.76M | 19.97M | 15.94M | 14.54M | 12.36M | 10.01M | 10.96M | 12.44M | 11.19M | 10.38M | 8.22M | 10.20M | 8.79M | 9.62M |
| Interest Income | 489.17K | 109.73K | 3.95K | 4.41K | 25.51K | 103.41K | 79.53K | 47.31K | 46.21K | 20.51K | 15.44K | 23.94K | 17.30K | 68.97K | 93.19K | 49.38K | 101.41K |
| Interest Expense | 215.99K | 265.92K | 89.31K | 207.86K | 280.26K | 26.13K | 20.08K | 17.95K | 25.42K | 107.26K | 270.26K | 383.79K | 355.24K | 198.30K | 137.50K | 253.96K | 223.61K |
| Depreciation & Amortization | 938.83K | 931.48K | 758.73K | 910.29K | 999.94K | 510.23K | 318.09K | 106.39K | 144.18K | 265.96K | 643.08K | 651.98K | 669.61K | 350.55K | 450.23K | 331.18K | 315.39K |
| EBITDA | -3.03M | -5.36M | -4.19M | -4.86M | -4.08M | -1.47M | -1.35M | 1.55M | 4.26M | 871.28K | -8.62M | 24.91K | 416.15K | 1.67M | 3.16M | 2.48M | 1.93M |
| EBITDA Ratio | -11.18% | -27.34% | -32.06% | -48.87% | -34.74% | -15.14% | -7.81% | 14.80% | 21.63% | 31.90% | -0.11% | 0.23% | -1.62% | 14.34% | 29.34% | 22.79% | 17.33% |
| Operating Income | -9.22M | -7.28M | -6.43M | -8.08M | -5.89M | -2.54M | -1.35M | 2.02M | 2.58M | 3.58M | -655.74K | -627.07K | -836.73K | 1.01M | 3.40M | 2.15M | 1.61M |
| Operating Income Ratio | -33.99% | -31.35% | -36.34% | -55.07% | -41.84% | -18.95% | -10.23% | 14.06% | 20.48% | 29.70% | -5.52% | -5.84% | -8.11% | 10.64% | 25.90% | 19.75% | 14.50% |
| Total Other Income/Expenses | 5.03M | -1.67M | -1.98M | -3.37M | 531.70K | -1.58M | 35.78K | 11.80K | 1.51M | -107.26K | -9.23M | -383.79K | -1.13M | -440.70K | -346.77K | -204.58K | -122.20K |
| Income Before Tax | -4.19M | -7.67M | -6.64M | -8.85M | -5.36M | -2.00M | -1.69M | 1.42M | 4.09M | 3.47M | -926.01K | -1.01M | -1.19M | 808.41K | 2.57M | 1.90M | 1.39M |
| Income Before Tax Ratio | -15.44% | -33.02% | -37.49% | -60.30% | -38.07% | -14.95% | -12.78% | 9.88% | 32.51% | 28.81% | -7.79% | -9.41% | -11.56% | 8.54% | 19.58% | 17.42% | 12.49% |
| Income Tax Expense | 511.08K | -1.05M | -1.60M | -2.81M | -2.45M | -1.97M | -160.88K | 529.98K | -702.71K | -595.31K | -146.05K | 33.27K | -235.75K | 358.30K | 523.01K | 139.41K | 258.50K |
| Net Income | -4.70M | -6.61M | -5.04M | -6.04M | -2.91M | -35.46K | -1.52M | 891.37K | 4.79M | 4.07M | -779.95K | -1.04M | -956.22K | 450.11K | 2.04M | 1.76M | 1.13M |
| Net Income Ratio | -17.32% | -28.47% | -28.47% | -41.18% | -20.69% | -0.26% | -11.56% | 6.20% | 38.09% | 33.75% | -6.56% | -9.72% | -9.27% | 4.76% | 15.59% | 16.14% | 10.17% |
| EPS | -0.05 | -0.07 | -0.06 | -0.08 | -0.04 | 0.00 | -0.02 | 0.02 | 0.09 | 0.07 | -0.01 | -0.01 | -0.03 | 0.01 | 0.06 | 0.06 | 0.04 |
| EPS Diluted | -0.05 | -0.07 | -0.06 | -0.08 | -0.04 | 0.00 | -0.02 | 0.02 | 0.08 | 0.07 | -0.01 | -0.01 | -0.03 | 0.01 | 0.06 | 0.06 | 0.04 |
| Weighted Avg Shares Out | 92.66M | 92.18M | 89.57M | 76.59M | 68.12M | 67.97M | 67.89M | 56.28M | 56.20M | 58.37M | 58.14M | 122.43M | 35.21M | 36.78M | 36.78M | 30.52M | 29.28M |
| Weighted Avg Shares Out (Dil) | 92.66M | 92.18M | 89.57M | 76.59M | 68.12M | 67.97M | 67.89M | 57.90M | 57.90M | 58.37M | 58.14M | 122.43M | 35.21M | 36.78M | 36.78M | 30.52M | 29.28M |
Source: https://incomestatements.info
Category: Stock Reports